Hatano H, Tanaka N, Naomoto Y, Orita K
First Department of Surgery, Okayama University Medical School, Japan.
Res Commun Mol Pathol Pharmacol. 1995 Sep;89(3):279-90.
Interferon-alpha (IFN-alpha) exhibits synergistic antitumor activity when combined with tumor necrosis factor-alpha (TNF-alpha) in vitro and in vivo and increases the cytotoxicity of 5-fluorouracil (5-FU) in vitro. Using a colon cancer cell line transplanted into nude mice, we examined the effects of pretreatment for 3 days with IFN-alpha (10(6) IU) and/or TNF-alpha (2.9 x 10(3) JRU) on 5-FU metabolism. 5-FU 30 mg/kg was administered after the pretreatment. IFN-alpha increased the tumor level of 5-fluorodeoxuridine monophosphate (FdUMP), and decreased the free level of thymidylate synthetase. Pretreatment with TNT-alpha alone decreased HUMP whereas TNF-alpha plus IFN-alpha abolished the enhancement of FdUMP production by IFN-alpha. TNF-alpha also suppressed thymidine kinase activity. Neither IFN-alpha nor TNF-alpha altered the incorporation of 5-FU into RNA.
α干扰素(IFN-α)在体外和体内与肿瘤坏死因子-α(TNF-α)联合使用时表现出协同抗肿瘤活性,并且在体外可增强5-氟尿嘧啶(5-FU)的细胞毒性。利用移植到裸鼠体内的结肠癌细胞系,我们研究了用IFN-α(10⁶ IU)和/或TNF-α(2.9×10³ JRU)预处理3天对5-FU代谢的影响。预处理后给予5-FU 30 mg/kg。IFN-α提高了5-氟脱氧尿苷单磷酸(FdUMP)的肿瘤水平,并降低了胸苷酸合成酶的游离水平。单独用TNF-α预处理可降低HUMP,而TNF-α加IFN-α则消除了IFN-α对FdUMP生成的增强作用。TNF-α还抑制胸苷激酶活性。IFN-α和TNF-α均未改变5-FU掺入RNA的情况。